MALP-2

 

References: History

  1. Effect of mycoplasmas on natural cytotoxic activity and release of tumor necrosis factor alpha by spleen cells.
    Lin Y, Collins JL, Case PG, Patek PQ. Infect Immun. 1988 Dec;56(12):3072-5.

  2. Tumor necrosis factor as a mediator of Mycoplasma orale-induced tumor cell lysis by macrophages.
    Gallily R, Sher T, Ben-Av P, Loewenstein J. Cell Immunol. 1989 Jun;121(1):146-53.

  3. Mycoplasma fermentans-derived high-molecular-weight material induces interleukin-6 release in cultures of murine macrophages and human monocytes.
    Quentmeier H, Schmitt E, Kirchhoff H, Grote W, Muhlradt PF. Infect Immun. 1990 May;58(5):1273-80.

  4. MDHM, a macrophage-stimulatory product of Mycoplasma fermentans, leads to in vitro interleukin-1 (IL-1), IL-6, tumor necrosis factor, and prostaglandin production and is pyrogenic in rabbits.
    Muhlradt PF, Schade U. Infect Immun. 1991 Nov;59(11):3969-74.

  5. Role of IL-6, IL-2, and IL-4 in the in vitro induction of cytotoxic T cells.
    Quentmeier H, Klaucke J, Muhlradt PF, Drexler HG. J Immunol. 1992 Nov 15;149(10):3316-20.

  6. MDHM, a macrophage-activating product of Mycoplasma fermentans, stimulates murine macrophages to synthesize nitric oxide and become tumoricidal.
    Ruschmeyer D, Thude H, Muhlradt PF. FEMS Immunol Med Microbiol. 1993 Oct;7(3):223-9

  7. Purification and partial biochemical characterization of a Mycoplasma fermentans-derived substance that activates macrophages to release nitric oxide, tumor necrosis factor, and interleukin-6.
    Muhlradt PF, Frisch M. Infect Immun. 1994 Sep;62(9):3801-7.

  8. Differential posttranslational processing confers intraspecies variation of a major surface lipoprotein and a macrophage-activating lipopeptide of Mycoplasma fermentans.
    Calcutt MJ, Kim MF, Karpas AB, Muhlradt PF, Wise KS. Infect Immun. 1999 Feb;67(2):760-71.

  9. Site-specific proteolysis of the MALP-404 lipoprotein determines the release of a soluble selective lipoprotein-associated motif- containing fragment and alteration of the surface phenotype of Mycoplasma fermentans.
    Davis KL, Wise KS. Infect Immun. 2002 Mar;70(3):1129-35.

  10. Association of Mycoplasma fermentans with Adamantiades-Behcet's disease.
    Zouboulis CC, Turnbull JR, Muhlradt PF. Adv Exp Med Biol. 2003;528:191-4.

  11. An evaluation of PCR methods to detect strains of Mycoplasma fermentans.
    Afshar B, Pitcher D, Nicholas RA, Miles RJ. Biologicals. 2008 Mar;36(2):117-21. Epub 2007 Sep 24.


top of page






References are directly linked to the according page on the NCBI (National Center for Biotechnology Information) web-page.